Health Care

Syngene reported Total revenue for Q4 FY23 of ₹994 Crore, up from ₹759 Crore year on year, a growth of…

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be…

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Q4 FY23 Earnings Concall dated Apr. 24, 2023. Corporate Participants: Unidentified Speaker -- Devinder Khurana -- Chief Financial…

Panacea Biotec Limited is an Indian pharmaceutical company that is engaged in research, development, and manufacturing of pharmaceuticals, vaccines, and…

“I am happy to report that our hospital business continued to deliver consistent performance in all key operational and financial…

“In FY24, Company’s profitability is expected to improve, driven by growth in Radiopharmaceuticals, Allergy Immunotherapy and CDMO Sterile Injectables businesses.…

“Strategic priority is to enhance our free cash generation and further debt reduction and we continue discussion with potential partners…

Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Management Update: [00:05:35] NEULANDLAB said its raw material prices…

Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY23 Earnings Concall Management Update: [00:05:37] SEQUENT said that in the API…

Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Management Update: [00:04:00] SUPRIYA said its primary focus remains…